Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with ...

Shares of Insulet Corp. PODD advanced 4.40% to $255.44 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 2.13% to 5,638.94 ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and ...

Penang can expect to have 600 EV charging bays by year-end, state local government, town and country planning committee chairman Jason H’ng Mooi Lye said today after opening an EV charging bay ...

Insulet Corporation (NASDAQ:PODD) showcases a strong financial performance with a ROIC of 16.28% and a WACC of 10.24%, indicating efficient capital use. Compared to peers like DexCom and Tandem ...

Highlights,Keybank National Association OH acquired a stake in Insulet Corp. (NASDAQ:PODD), demonstrating heightened institutional involvement.,Multiple financial institutions adjusted their holdings ...

Insulet experienced a 12% decline in its stock price over the past week following its earnings announcement and corporate guidance. The company reported strong year-over-year sales growth, however ...

Insulet Corporation (NASDAQ:PODD), a medical device company with a market capitalization of $17.68 billion, has announced an extension and amendment to its existing agreement with NXP (NASDAQ:NXPI) ...

Penang and Langkawi have gorgeous skies and seas, perfect for a vacation. Aside from Malaysia’s metropolis, these two destinations are also popular among locals and tourists. Since Penang and Langkawi ...

Insulet has a 12-month low of $160.19 and a 12-month high of $289.46. The company has a market cap of $17.68 billion, a PE ratio of 43.49, a price-to-earnings-growth ratio of 3.62 and a beta of 1.29.

Insulet’s Omnipod 5 with the Dexcom G6 CGM. [Image from Insulet] A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young people.